SKLB610
Catalog No. A13465
SKLB610是一种新型的血管内皮生长因子受体酪氨酸激酶抑制剂,在体内具有抑制血管生成和肿瘤生长的作用。
Catalog Num | A13465 |
---|---|
M. Wt | 415.11 |
Formula | C21H16F3N3O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1125780-41-7 |
Synonyms | SKLB 610, SKLB-610 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)C(F)(F)F |
SKLB610是一种新型的血管内皮生长因子受体酪氨酸激酶抑制剂,在体内具有抑制血管生成和肿瘤生长的作用。
In vitro | DMSO | 77 mg/mL (185.38 mM) | |
Water | Insoluble | ||
Ethanol | 25 mg/mL (60.19 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.09 mL | 120.45 mL | 240.9 mL |
0.5 mM | 4.82 mL | 24.09 mL | 48.18 mL |
1 mM | 2.41 mL | 12.05 mL | 24.09 mL |
5 mM | 0.48 mL | 2.41 mL | 4.82 mL |
*The above data is based on the productmolecular weight 415.11. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.